Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...

Tempus AI (TEM) announced a new collaboration with the Institute for Follicular Lymphoma Innovation. The collaboration aims to develop and make ...

Thomas Fuller / SOPA Images / LightRocket via Getty Images Tempus AI (TEM) shares soared to an all-time high Thursday, extending their recent rally as the tech firm announced a collaboration with ...

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared to its daily average volume of about 5.67 million. All thanks to three ...

In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as ...

Shareholders in Tempus AI, Inc. (NASDAQ:TEM) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated revenue numbers ...

Investors with a lot of money to spend have taken a bullish stance on Tempus AI TEM. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Tempus AI announced a collaboration with the Institute for Follicular Lymphoma Innovation. The goal of the collaboration is to advance targeted therapy development for follicular lymphoma by ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other large-cap stocks. We previously covered 10 Large-Cap Stocks Insiders Are Buying Recently.

Tempus AI recently completed the acquisition of Ambry Genetics. The transaction enables it to expand into other areas of healthcare. Management projects strong year-over-year revenue growth for 2024.